openPR Logo
Press release

Shiba Inu (SHIB) 21.5% February Correction or Taurox (TAUX): Why Smart Investors Pick 100x Instead

03-20-2026 02:51 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Ignix Media

Shiba Inu (SHIB) 21.5% February Correction or Taurox (TAUX): Why

SHIB dropped 21.5% in February, marking one of the worst months in its recent history. The correction followed a brief January bounce that failed to hold any technical support levels on the daily chart. Two consecutive months of losses with declining volume suggests sellers remain firmly in control with no clear floor forming.

The January bounce was a dead cat: price briefly reclaimed a range, volume dried up within days, and sellers pushed through support without meaningful resistance. When a token cannot hold gains during a relief rally, the next leg down finds fewer buyers and wider spreads.

Taurox (https://taurox.io/) is a decentralized hedge fund where AI agents will execute trades against real markets once the presale concludes and the pool goes live. Performance depends on agent strategy and execution, not on hoping a chart reversal holds against declining volume.

How Agent Selection Works: Performance Over Reputation

Anyone can submit agents to the Taurox (https://taurox.io/) protocol: developers, quants, and AI builders from anywhere in the world. Entry is performance-gated, not reputation-gated. Agents never hold funds directly. They trade through vault contracts on DEXs or through sub-accounts on CEXs, with zero withdrawal rights over pool capital at any point.

Each agent operates autonomously within defined risk boundaries set by the protocol's risk framework. Taurox provides the capital. Agents provide the strategy and their own data infrastructure. The protocol does not supply signals or market data, meaning agents must source their own edge independently. This creates an open marketplace for trading talent where measurable results determine allocation size, not credentials or industry connections.

Stakers keep 80% of net profits at the standard tier. SHIB lost 21.5% in a single month with no mechanism to slow the decline or protect holder capital. Taurox filters agents by verifiable output, and stakers benefit from whichever strategies perform best across market conditions. One relies on sentiment recovery. The other relies on meritocratic competition among autonomous traders.

Phase 1 Speed Tells You Where Real Conviction Lives

Phase 1 of the TAUX (https://taurox.io/) presale sold out in under 24 hours at $0.01. Phase 1 buyers are up 20% at the current Phase 2 price of $0.012. The presale has raised $314.7K, and Phase 2 is 23.9% filled. Each phase has a fixed allocation that closes permanently when sold out. The price steps up to the next tier, and the previous entry vanishes from the structure. There are no extensions and no repricing at any stage. SHIB holders watched a 21.5% February correction erase a January bounce that already had no momentum behind it.

TAUX presale buyers enter at a fixed price with a clear activation timeline: staking begins at the end of the presale, and agents will start executing against live markets. One token lost a fifth of its value in 28 days with no floor in sight. The other has a rising floor built directly into its phase structure. Phase 2 is filling, and $0.012 is the current entry. When this allocation closes, the next price will be higher.

TAUX at $0.012: What the Numbers Show

Phase 2 is live at $0.012. Listing at $0.08 gives buyers 6.67x from the current entry. A $1 post-listing price is 100x. At a $1 billion pool with 30% gross returns, implied TAUX price reaches $1.85, or x154 from today. Zero management fees in the structure. The protocol charges 5% on profits only. Thirty percent of collected fees burn permanently as TAUX tokens.

The remaining 70% funds the DAO treasury. Supply is fixed at 2 billion tokens with no minting function in the contract. Each fee cycle compresses circulating supply against a ceiling that never moves. The presale has raised $314.7K, and Phase 2 is 23.9% filled. Phase 2 is filling now.
Learn More
Buy TAUX: https://taurox.io/
Whitepaper: https://docs.taurox.io/
Official Telegram: https://t.me/tauroxlabs

Contact: Samuel Pierce
Email: Samuel@IgnixMedia.com

Decentralized, non-custodial protocol connecting capital with autonomous trading agents.
Algorithmic allocation. Transparent performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Shiba Inu (SHIB) 21.5% February Correction or Taurox (TAUX): Why Smart Investors Pick 100x Instead here

News-ID: 4432000 • Views:

More Releases from Ignix Media

Solana (SOL) $650B Stablecoin Volume Yields Nothing Next to Taurox (TAUX), Analysts Point to 100x
Solana (SOL) $650B Stablecoin Volume Yields Nothing Next to Taurox (TAUX), Analy …
Solana leads all blockchains with $650 billion in monthly stablecoin transfer volume. The network processed more stablecoin value than Ethereum, Tron, and Arbitrum combined last month. USDC dominates at 53.81% of Solana's $15.7 billion stablecoin base. Yet SOL remains flat on the year, and none of this transfer volume generates yield for token holders. Validators collect fees. Stakers earn single-digit APY. Spot holders earn zero. The network has become the
Dogecoin (DOGE) Has Only 22 Developers Next to Taurox (TAUX), Analysts Point to Taurox (TAUX) for 100x Potential
Dogecoin (DOGE) Has Only 22 Developers Next to Taurox (TAUX), Analysts Point to …
Dogecoin has 22 full-time developers. Ethereum has 31,869. Solana has 17,708. That gap is not a rounding error. It represents a structural deficit in ecosystem development that no memecoin rally can fix. DOGE has no DeFi protocols, no total value locked, and no smart contracts on its base layer. The network processes payments and nothing else. Development activity is the foundation of long-term protocol growth, and Dogecoin's foundation is thinner
Dogecoin (DOGE) Derivatives Hit $1.15B Open Interest While Taurox (TAUX) Presale Hits $329K at Phase 2
Dogecoin (DOGE) Derivatives Hit $1.15B Open Interest While Taurox (TAUX) Presale …
DOGE derivatives open interest sits at $1.15B with futures volume reaching $4B per day, dwarfing spot volume of $523M at an 8:1 ratio. The leveraged tail wags the spot dog. Price is driven by futures positioning, not by organic buying or real utility demand. Leveraged traders amplify moves in both directions, creating volatility that benefits exchanges collecting funding rates, not holders hoping for appreciation. The 8:1 derivatives-to-spot ratio means that
Shiba Inu (SHIB) 45B Exchange Outflow Looks Weak Next to Taurox (TAUX), Presale Hits $314K in Phase 2
Shiba Inu (SHIB) 45B Exchange Outflow Looks Weak Next to Taurox (TAUX), Presale …
Forty-five billion SHIB left exchanges in 24 hours as the price surged 10%. The community interprets large outflows as bullish accumulation, a signal that holders are moving tokens to cold storage with no intention to sell. The narrative sounds convincing until you run the numbers. Forty-five billion tokens is 0.0076% of SHIB's 589 trillion circulating supply. That percentage is statistically insignificant, the equivalent of removing a single drop from a

All 5 Releases


More Releases for Phase

Three-Phase Hybrid Inverter Market Efficient and Reliable Power Conversion Solut …
Global Three-Phase Hybrid Inverter Market Overview: The Three-Phase Hybrid Inverter market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Three-Phase Hybrid Inverter market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth
Clinical Trials by Phase (Phase I, Phase II, Phase III, Phase IV) Market Forecas …
A clinical trial is a research study, where a group of people is given a test or treatment. Clinical trials study the safety and efficacy of tests and treatments. If the test or treatment is safe and meets regulatory requirements, then it is approved as a standard of care. Download Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00006203/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  IQVIA  Parexel International Corporation  Charles River Laboratories  ICON plc  SGS SA  Chiltern International Ltd  Syneos Health  PRA Health Sciences  Wuxi AppTec Inc  Pharmaceutical Product Development,
Digital Phase Shifters Market
Digital Phase Shifters Market A recently identified vacuum in the literature about the creation of digital phase shifters for modern communication systems is attempted to be filled in the book Design of Digital Phase Shifters for Multipurpose Communication Systems. By significantly reducing RF power consumption and improving noise immunity, directed beams enhance the development of new-generation mobile communication systems. In this regard, digital phase shifters in particular, which are part
COVID-19 - Pipeline Analysis 2020 for Global Market | Emphasis on Products cover …
COVID-19 (also known as Anderson COVID-19)?is a viral disease caused by RNA virus, SARS-CoV-2 or commonly known as corona virus. These viruses can cause respiratory, enteric, hepatic, and neurologic diseases. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China. It rapidly spread, resulting in an epidemic throughout China, followed by an increasing number of cases in other
Power Metering Market Information by type (smart, digital, analog), by phase (si …
Power Metering Market Information by type (smart, digital, analog), by phase (single phase, three phase) by application (residential, commercial and industrial) and Region - Forecast to 2022 The report for Global Power Metering Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and
HIV Vaccines Market Perceive Aggrandized Growth at a CAGR of 11.48% Till 2023 | …
HIV Vaccines Market Report Added on MarketResearchFuture.com with Overall Analysis. Key developments and Strategies Cover in this Report. The Market for Expected to Grow Globally Over the CAGR of 5 % During the Period 2018 to 2027 from USD 2,702.3 Billion in 2027. HIV Vaccines Market - Segmentation The global HIV vaccines market has been segmented on the basis of basis of antibiotics, type, and lastly, region. Antibiotics have been segmented into dicloxacillin,